Bolt Biotherapeutics, Inc. Earnings Per Share (Basic)
Bolt Biotherapeutics, Inc. (BOLT) reported Earnings Per Share (Basic) of -$4.57 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Bolt Biotherapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$4.57.
- Bolt Biotherapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$4.31.
- Bolt Biotherapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$3.84.
- Bolt Biotherapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$3.72.
- Bolt Biotherapeutics, Inc. earnings per share, basic for fiscal 2025 was -$17.85.
- Bolt Biotherapeutics, Inc. earnings per share, basic for fiscal 2024 was -$33.06.
- Bolt Biotherapeutics, Inc. earnings per share, basic for fiscal 2023 was -$1.83.
- Bolt Biotherapeutics, Inc. earnings per share, basic for fiscal 2022 was -$2.36.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.57 10-Q · filed 2026-08-11 | -$8.88 10-Q · filed 2026-08-11 | -$12.71 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$16.38 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2026-03-31 | -$4.31 10-Q · filed 2026-05-12 | -$8.15 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$11.84 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$16.34 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2025-12-31 | -$3.84 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$7.56 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$12.05 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$17.85 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$3.72 10-Q · filed 2025-11-12 | -$8.19 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$13.94 10-Q · filed 2025-11-12 | -$22.26 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2025-06-30 | -$4.46 10-Q · filed 2026-08-11 | -$10.22 10-Q · filed 2026-08-11 | -$18.54 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$26.48 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2025-03-31 | -$5.76 10-Q · filed 2026-05-12 | -$0.29 10-Q · filed 2025-05-12 | -$14.08 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$22.02 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$33.12 derived: net income ÷ weighted average shares · filed 2026-05-12 | |||
| 2024-12-31 | -$8.32 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$16.26 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$27.37 derived: net income ÷ weighted average shares · filed 2026-03-12 | -$33.06 10-K · filed 2026-03-12 | -$1.65 10-K · filed 2025-03-24 | |||
| 2024-09-30 | -$7.93 10-Q · filed 2025-11-12 | -$0.40 10-Q · filed 2024-11-12 | -$19.05 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$24.73 10-Q · filed 2025-11-12 | -$1.24 10-Q · filed 2024-11-12 | -$3.26 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||
| 2024-06-30 | -$11.12 10-Q · filed 2025-08-14 | -$0.56 10-Q · filed 2024-08-13 | -$16.80 10-Q · filed 2025-08-14 | -$0.84 10-Q · filed 2024-08-13 | -$1.92 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$2.29 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||
| 2024-03-31 | -$0.28 10-Q · filed 2025-05-12 | -$0.76 derived: net income ÷ weighted average shares · filed 2025-05-12 | -$1.18 derived: net income ÷ weighted average shares · filed 2025-05-12 | -$1.66 derived: net income ÷ weighted average shares · filed 2025-05-12 | ||||
| 2023-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$0.90 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$1.38 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$1.83 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | -$0.43 10-Q · filed 2024-11-12 | -$0.91 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.36 10-Q · filed 2024-11-12 | -$1.89 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2023-06-30 | -$0.48 10-Q · filed 2024-08-13 | -$0.93 10-Q · filed 2024-08-13 | -$1.46 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$2.04 derived: net income ÷ weighted average shares · filed 2024-08-13 | ||||
| 2023-03-31 | -$0.45 10-Q · filed 2024-05-14 | -$0.98 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.56 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$2.17 derived: net income ÷ weighted average shares · filed 2024-05-14 | ||||
| 2022-12-31 | -$0.53 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$1.11 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$1.72 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$2.36 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | -$0.58 10-Q · filed 2023-11-09 | -$1.19 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.83 10-Q · filed 2023-11-09 | -$2.55 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||||
| 2022-06-30 | -$0.61 10-Q · filed 2023-08-07 | -$1.25 10-Q · filed 2023-08-07 | -$1.97 derived: net income ÷ weighted average shares · filed 2023-08-07 | -$2.60 derived: net income ÷ weighted average shares · filed 2023-08-07 | ||||
| 2022-03-31 | -$0.64 10-Q · filed 2023-05-11 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$1.99 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$2.64 derived: net income ÷ weighted average shares · filed 2023-05-11 | ||||
| 2021-12-31 | -$0.73 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$1.36 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$2.00 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$2.97 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | -$0.63 10-Q · filed 2022-11-10 | -$1.27 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$2.24 10-Q · filed 2022-11-10 | -$4.21 derived: net income ÷ weighted average shares · filed 2022-11-10 | ||||
| 2021-06-30 | -$0.64 derived: net income ÷ weighted average shares · filed 2022-08-10 | -$1.65 derived: net income ÷ weighted average shares · filed 2022-08-10 | -$3.94 derived: net income ÷ weighted average shares · filed 2022-08-10 | -$5.73 derived: net income ÷ weighted average shares · filed 2022-08-10 | ||||
| 2021-03-31 | -$1.14 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$4.70 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$7.68 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$11.12 derived: net income ÷ weighted average shares · filed 2022-05-12 | ||||
| 2020-12-31 | -$14.76 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$20.09 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$25.95 derived: net income ÷ weighted average shares · filed 2022-03-30 | -$30.53 derived: net income ÷ weighted average shares · filed 2022-03-30 | ||||
| 2020-09-30 | -$5.04 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$10.74 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$15.22 derived: net income ÷ weighted average shares · filed 2021-11-09 | |||||
| 2020-06-30 | -$5.71 derived: net income ÷ weighted average shares · filed 2021-08-12 | -$10.17 derived: net income ÷ weighted average shares · filed 2021-08-12 | ||||||
| 2020-03-31 | -$4.46 derived: net income ÷ weighted average shares · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |